An inside look at how multi-cancer early detection screenings are shaking up the health care industry.

As Americans, we've become accustomed to the nearly unique experience of seeing commercials for medicines like prescription drugs on television—only the U.S. and New Zealand allow this kind of ...

Dec. 2 (UPI) --As new blood tests capable of detecting dozens of cancers in their early stages are hitting the market, disease prevention advocates say political and economic momentum is building for ...

Multi-cancer early detection tests (MCEDs), sometimes called liquid biopsy tests, are a new method of detecting cancer early. While the concept is promising, these untested tests currently pose ...

The Biden-Harris Administration recently re-launched the Cancer Moonshot, setting ambitious goals to cut the rate of cancer deaths by half over the next quarter century and to improve the clinical ...

Multicancer early detection tests (MCEDs), sometimes referred to as liquid biopsies, are tests that can screen for multiple cancers by analyzing blood, urine, and other bodily fluids for biomarkers ...

Blood tests for dozens of types of cancer have been invented. These tests, known as liquid biopsies, could save tens of millions of lives. That’s because there’s currently no good screening procedures ...

As Americans, we’ve become accustomed to the nearly unique experience of seeing commercials for medicines like prescription drugs on television—only the U.S. and New Zealand allow this kind of ...

Financial Toxicity and Breast Cancer: Why Does It Matter, Who Is at Risk, and How Do We Intervene? Multicancer early detection tests (MCEDs), sometimes referred to as liquid biopsies, are tests that ...